Profound Medical (PROF) Q1 2024 Earnings
PROF·Reported May 9, 2024·After market close
Profound Medical reported Q1 2024 revenue of $1.4M, missed analyst consensus of $2.5M by $1.1M. Diluted EPS came in at $-0.26, beat the $-0.30 consensus by $0.04.
Revenue
$1.4Mmissed by $1.1M
Consensus: $2.5MDiluted EPS
$-0.26beat by $0.04
Consensus: $-0.30
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Profound Medical's Q1 2024 earnings report.
Profound Medical (PROF) reported Q1 2024 earnings on May 9, 2024 after market close.
Profound Medical reported revenue of $1.4M and diluted EPS of $-0.26 for Q1 2024.
Revenue missed the consensus estimate of $2.5M by $1.1M. EPS beat the consensus estimate of $-0.30 by $0.04.